1,596
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Chronic Obstructive Pulmonary Disease and Asthma–Patient Characteristics and Health Impairment

, , , , , , & show all
Pages 256-266 | Published online: 23 Oct 2013

References

  • Mannino DM, Buist AS. Global burden of COPD risk factors, prevalence, and future trends. Lancet 2007; 370:765–773.
  • Meltzer EO, Blaiss MS, Nathan RA, Asthma burden in the United States: Results of the 2009 asthma insight and management survey. Allergy Asthma Proc. 2012; 33(1):36–46.
  • Kochanek KD, Xu JQ, Murphy L, Deaths, preliminary data for 2009. Natl Vital Stat Report. 2011; 59(4). US Dept of Health and Human Services, CDC, National Center for Health Statistics; 2011. Available at http://www.cdc.gov/nchs/nvsr/nvsr59/nvsr59_04.pdf
  • Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997; 349:1436–1442.
  • Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998–2009. NCHS data brief, no 63. Hyattsville, MD: National Center for Health Statistics, 2011.
  • Verbugge LM, Patrick DL. Seven chronic conditions: their impact on US adults’ activity levels and use of medical services. Am J Public Health 1995; 85:173–182.
  • Bousquet J, Khaltaev (eds). Global Surveillance, Prevention, and Control of Chronic Respiratory Diseases: a Comprehensive Approach. World Health Organization; 2007 Available at http://www.who.int/gard/publications/GARD%20Book%202007.pdf
  • Eisner MD, Iribarren C, Blanc PD, Development of disability in chronic obstructive pulmonary disease: beyond lung function. Thorax 2011; 66:108–114.
  • Braido BF, Baiardini I, Menoni S, Disability in COPD and its relationship to clinical and patient-reported outcomes. Curr Med Res Opin 2011; 27:981–986.
  • Zhang MWB, Ho RCM, Cheung MWL, Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry 2011; 33:217–223.
  • Katz PP, Juliam LJ, Omachi TA, The impact of disability on depression among individuals with COPD. Chest 2010; 137:838–845.
  • Cecere LM, Littman AJ, Slatore CG, Obesity and COPD: Associated symptoms, health-related quality of life, and medication use. J Chronic Obstruct Pulm Disease 2011; 8:275–284.
  • Brown DW, Pleasants R, Ohar JA, Health-related quality of life and chronic obstructive pulmonary disease in North Carolina. N Am J Med Sci 2010; 2:60–65.
  • Tsiligianni I, Kocks J, Tisanikas N, Siafakas N. Factors that influence disease-specific quality of life or health status in patients with COPD: a systematic review and meta-analysis Pearson correlations. Prim Care Res J 2011; 20:257–268.
  • Voll-Aanerud M, Eagan TM, Wentzel-Larsen T, Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respir Med 2008; 102:399–406
  • Wijnhoven HA, Kriegsman DM, Hesselink AE, The influence of co-morbidity on health-related quality of life in asthma and COPD patients. Respir Med 2003; 97:468–475.
  • Katsura H, Yamada K, Kida K. Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD. Respir Med 2005; 99:624–630.
  • Omachi TA, Katz PP, Elin EH Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med 2009;122:778.e9-778.e15.
  • Eisner MD, Iribarren C, Blanc PD, Development of disability in chronic obstructive pulmonary disease: beyond lung function. Thorax 2011; 66:108–114.
  • Garcia-Rio F, Lores V, Mediano O, Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Resp Crit Care Med 2009; 180:506–512.
  • Augusti A, Soriano JB. COPD as a systemic disease. COPD 2008; 5:133–138.
  • Patel ARC, Hurst JR. Extrapulmonary co-morbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 2011; 5:647–662.
  • Barnes P, Celli B. Systemic manifestations and co-morbidites in COPD. Eur Resp J 2009; 33:165–85
  • Shaya FT, Dongyi D, Akazawa MO, Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008; 134:14–19.
  • Mapel DW, Dutro MP, Marton JP, Identifying and characterizing COPD patients in US managed care: a retrospective, cross-sectional analysis of administrative claims data. BMC Health Services Res 2011; 11:43.
  • Blanchette CM, Gutierrez B, Ory C, Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare advantage population. J Man Care Pharm 2008; 14:176–185.
  • Soriano JB, Davis KJ, Coleman B, The proportional Venn diagram of obstructive lung disease: two approximations form the US and UK. Chest 2003; 124:474–481.
  • Sidney S, Sorel M, Quesenberry CP, COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005;128:2068–2075.
  • Curkendall SM, DeLuise C, Jones JK, Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16:63–70.
  • Hardin M, Silverman EK, Barr G, The clinical features of the overlap between COPD and asthma. Respir Res 2011; 12:127–132.
  • Centers for Disease Control and Prevention. Public Health Strategic Framework for COPD Prevention. Atlanta, GA: Centers for Disease Control and Prevention; 2011. Available at http://www.cdc.gov/copd/pdfs/Framework_for_COPD_Prevention.pdf
  • Mannino DM. Institute of Medicine. A Nationwide Framework for Surveillance of Cardiovascular and Chronic Lung Diseases. Washington DC: The National Academies Press; 2011. Available at http://www.iom.edu/Reports/2011/A-Nationwide-Framework-for-Surveillance-of-Cardiovascular-and-Chronic-Lung-Diseases.aspx
  • Herrick H, Pleasants R, Wheaton A, Liu Y Chronic obstructive pulmonary disease and associated health-care resource Use — North Carolina, 2007 and 2009. MMWR Morb Mortal Wkly Rep 2012; 61:143–146.
  • Centers for Disease Control and Prevention –USA. Behavioral Risk Factor Surveillance System Operational and User's Guide (http://www.cdc.gov/brfss), Atlanta, GA, 1998.
  • Centers for Disease Control and Prevention –USA. Behavioral Risk Factor Surveillance System 2007 Summary Data Quality Report (http://www.cdc.gov/brfss)
  • Centers for Disease Control and Prevention –USA. Behavioral Risk Factor Surveillance System 2009 Summary Data Quality Report (http://www.cdc.gov/brfss)
  • US Census Bureau, 2010 census, North Carolina. Accessed online March 12, 2012 at http://www.2010census.nc.gov
  • Akinbami L, Moorman JE, Liu X. Asthma prevalence, healthcare use, and mortality: United States; 2005–2009. Hyattsville, MD, National Health Statistics Report No. 32, National Center for Health Statistics, 2011.
  • Kosacz N, Punturieri A, Croxton T, Chronic obstructive pulmonary disease among adults –United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:938–943.
  • Zharan HS, Bailey C, Garbe P. Vital signs: asthma prevalence, disease characteristics, and self-management education—United States, 2001–2009. MMWR Morb Mortal Wkly Rep May 6, 2011 60:547–552.
  • Haahtela T, Tuomisto LE, Pientinalho A, A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61:663–670.
  • Ford ES, Mannino D. Time trends in obesity among adults with asthma in the US; findings from three national surveys. J Asthma 2005; 42(2):91–95.
  • Poulain M, Doucet M, Major G, The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. Can Med J 2006; 174(9):1293–1299.
  • Methvin J, Mannino D, Casey B. COPD prevalence in Southeastern Kentucky: the burden of lung disease study. Chest 2008; 135:102–107.
  • Divo M, Cote C, de Torres J, Co-morbidities and mortality in patients with chronic obstructive pulmonary disease. Am J Resp Crit Care Med 2012; 186;155–161.
  • Mannino D, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in COPD. Eur Resp J 2008; 32:962–969.
  • Miravitlles M, Soriano J Anchochea J, Characterisation of the overlap COPD–asthma phenotype. Focus on physical activity and health status. Resp Med 2013; 107:1053–1060.
  • Putcha N, Puhan M, Hansel N, Drummond M, Boyd C. Impact of co-morbidities on self-rated health in self-reported COPD: An analysis of NHANES 2001–2008. COPD 2013: 10:324–332.
  • State Center for Health Statistics. North Carolina Department of Health and Human Services. BRFSS 2009. http://epi.state.nc.us/SCHS/BRFSS/nc/all. Accessed April 22, 2012.
  • Eisner MD, Blanc PD, Omachi A, Socioeconomic status, race, and COPD health outcomes. J Epidemiol Commun Health 2011; 65:26–34.
  • Miravitlles M, Naberan K, Cantoni J, Azpeitia A. Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration 2011; 82:402–408.
  • Kanervisto M, Vasankari T, Laitnen T, Low socioeconomic status is associated with chronic obstructive airways diseases. Resp Med 2011; 105:1140–1146.
  • Nguyen K, Zahran H, ../../../Documents and Settings/ikd8/Local Settings/Temporary Internet Files/Content.Outlook/AppData/Local/Microsoft/Windows/pubmed%3fterm = %22Iqbal S%22%5bAuthor%5d et al. Factors associated with asthma control among adults in five New England states, 2006–2007. J Asthma 2011; 48:581–588.
  • Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004; 126:59–65.
  • Kauppi P, Kupiainen KH, Lindqvist A, Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011; 48:279–285.
  • Shaya FT, Dongyi D, Akawaza MO, Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008; 134:14–19.
  • Pleasants R, Herrick H, Liao W, Ohar J. Use of a US population-based survey to describe the relationship of COPD and co-morbidities. Eur Resp J 2011; 38(Supp 55):182s.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.